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in Post Cardiac Arrest Patients
Timothy Hovde PA-S
Department of Physician Assistant Studies, University of North Dakota School of Medicine & Health Sciences
Grand Forks, ND   
• To acquire relevant research PubMed, Clinical Key, Cochrane review and
Google Scholar were referenced.
• Search terms included; targeted temperature management, therapeutic
hypothermia, cardiac arrest, return of spontaneous circulation (ROSC)
and neurological. These terms were used in several combinations to
obtain appropriate research materials.
• Dynamed and the American Heart Association (AHA) were further
assessed for recommendations on patient selection, implementation, and
methodology behind TTM
• Studies performed both on in-hospital cardiac arrest (IHCA) as well as
out-of-hospital cardiac arrest (OHCA) were included to assess the use of
TTM prehospital. Furthermore, TTM use in pediatric patients as well as
in shockable and non-shockable rhythms was assessed through literature
review.
• Novel methods of ensuring survival following cardiac arrest and
resuscitation are of supreme importance to the medical community.
Targeted temperature management (TTM) has become increasingly
utilized pre-hospital, in emergency departments, and within intensive care
units to increase the likelihood of survival to hospital discharge. TTM has
further been used to attempt to improve neurological functioning. The
efficacy and mechanism behind TTM remains poorly understood. In
several patient populations it also remains unproven. The purpose of this
study is to assess the physiological mechanism, survival, neurological
recovery and methodology of TTM use and implementation.
• Literature review was utilized to assess the physiological mechanism by
which TTM elicits its neuroprotective effects. Statistics on neurological
outcomes and survival rates were further examined. Finally, the
proposed method to safely and efficiently induce and maintain TTM in
appropriate patients was also assessed through literature review.
• TTM was found to improve survival and neurological functioning in adults
suffering cardiac arrest both in-hospital and out-of-hospital. No
improvement has been noted in studies on pediatric patients, thus TTM is
not indicated in pediatric patients. Animal studies demonstrate a
decrease in cerebral edema and mitochondrial apoptosis of neuronal
cells with TTM application. Serum biomarkers of brain injury and
disfunction of the endothelial lining constituting the brain blood barrier
(BBB) have also been found to be decreased in patients undergoing
TTM. Finally, serum assay of antioxidants demonstrates a decrease in
oxidative damage and increase in antioxidant protection following
reperfusion.
• Targeted temperature management is a poorly understood intervention.
It is believed to confer benefit to survival and neurological outcome,
though the mechanism is still under research. The magnitude of potential
benefit to survival and neurological functioning also remains under
scrutiny. Finally, the method of TTM induction remains poorly
standardized. Assessment into the methods and procedures of several
studies may yield data on the most effective and efficient method to
confer the greatest benefit to survival and neurological function.
• By what proposed mechanisms does targeted temperature management
improve survivability and neurological functioning following cardiac arrest
and resuscitation?
• Do studies evaluating the benefit of targeted temperature management
demonstrate statistically significant improvements in survival to hospital
discharge as well as improvements in cognitive function following
resuscitation?
• What is the currently agreed upon method of inducing targeted
temperature management and what is its ease of implementation?
• Pathophysiology
o Fan et al. (2017) utilized a rat model to show increased DRP-1 and CYT-
C as well as morphological changes in mitochondria in all cardiac arrest
groups (P < 0.05) suggesting decreased mitochondrial induced neuronal
apoptosis (P < 0.05).
o Hackenhaar et al. (2017) performed a study focused on reactive oxygen
species (ROS) development. TTM was effective in decreasing reactive
oxygen species(P < 0.05)
o Jahandiez, et al. (2017) ) performed studies using rabbits to model
cardiac arrest. A decrease in mitochondrial apoptosis was noted (P <
0.05).
o Jieben et al (2017) performed a series of porcine studies assessing the
effects of TTM. The TTM cohort demonstrated improvement on
examination of neurological structures, and diminished serum
biomarkers indicating epithelial destruction (P < 0.05). Jieben et al.
(2017) further evaluated damage to vascular endothelium. The serum
ANG-1 and ANG-2 of the TTM cohort demonstrated fewer irregularities
suggesting minimized damage to vascular endothelium (P < 0.1)
o Chen et al. (2017) performed controlled studies using endothelial cells of
laboratory rats. Ischemic cells in the TTM group demonstrated a
decrease in apoptosis (P < 0.0083). The CYT-C precursor Bax as well
as caspase 3 were elevated to a lesser degree in the TTM cohort (P <
0.05).
• Survival and cognition improvements
o Fan, et al. (2017) performed an experiment performing TTM on lab rats.
Improvements were noted in the TTM group in survival and neurological
function. (P = 0.05).
o Nurnberger et al. (2017) utilized data obtained from the Circulation
Improving Resuscitation Care Trial (CIRCT). The results suggest that
survival to discharge is superior in patients who receive prehospital/in-
hospital TTM (P = 0.006).
o Moler at al. (2017) performed a study to determine the efficacy of TTM
for pediatric patients who experience IHCA. No significant difference
was found in survival, nor was there difference in cognitive function (P =
0.56, P = 0.63, respectively).
o Perman et al. (2015) used retrospective analysis to determine the
effectiveness of TTM who present with a non-shockable rhythm
(Asystole/PEA). Both cohorts enjoyed improved neurological functioning
and survivability to discharge regardless of the location of arrest (P =
0.003, P = 0.001 respectively).
• Method of implementation
o Casamento et al. (2016) utilized review of patient records to assess
varying magnitudes of TTM. Patients underwent TTM at 32-34 degrees,
or TTM at 36 degrees. Greater likelihood of complications was found in
the 32-34-degree group (P = 0.01). They also note an increased
discharge to home rate in the 36-degree group (P = 0.02).
o Yuan et al. (2017) performed a porcine study on the effects of early
versus delayed administration of TTM. CPC scores demonstrated








• Patients who underwent an out-of-hospital cardiac arrest (OHCA) had a
12% likelihood of surviving to discharge (Chan, Mcnally, Tank &
Kellerman, 2014), and the likelihood of retaining good neurological
function is 8.5% (Buick et al., 2018).
• Targeted temperature management has become a mainstay within
hospital systems to improve neurological function in patients after
cardiac arrest
• Proponents further suggest that implementation improves survival to
hospital discharge.
• The probable neuroprotective mechanism, improvements in survival
and neurological functioning, and recommendations for implementation
were assessed through literature review.
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• Animal studies performed by Fan et al. (2017) and Chen et al. (2017)
demonstrate inhibition of mitochondrial induced cellular apoptosis through
alteration of mediators of mitochondrial pore opening such as CYT-C,
Caspase-3 and Bax.
• Further protection is offered due to the increase in anti-apoptotic factors
such as Bcl-2. This interferes with neuronal apoptosis as well as
ensuring the continued function of microvascular endothelium. As a
result, further injury due to damage to the BBB and subsequent free
radical damage and cerebral edema was prevented.
• There is a clear benefit to survival and neurological recovery when TTM
is applied to adults undergoing IHCA and OHCA with an initially
shockable rhythm.
• Improvements were noted in survival, and in neurological functioning as
measured by autonomic reflexes and operationally defined observation
for 24-72 hours post-resuscitation in animal studies Improvement in
survivability and neurological outcome has also been noted in
retrospective assessment of patient records.
• The benefit of TTM to survivability and neurological outcome is supported
in patients with a non-shockable cardiac rhythm. Perman, Grossestreuer,
Douglas, Wiebe, Carr, Abella (2015) found statistical significant
improvements in patient survival with TTM vs normothermia when the
initial presenting rhythm is non-shockable. (29% vs 15%, P = .001).
Continued assessment found patients are more likely to be discharged
neurologically intact if TTM is utilized following resuscitation in
PEA/Asystole (OR 2.1; 95% CI 1.01-4.36).
• The studies do not currently support the use of TTM in pediatric patients
due to lack of efficacy. This may be due to the different causalities in
pediatric cardiac arrest.
• Earlier application of TTM is associated with improved likelihood of
neurological improvement. TTM application prior to ED arrival however,
is controversial. TTM appears to elicit its effects during reperfusion.
Prolonged cardiac arrest, or prolonged time until TTM application is likely
to diminish the potential benefit.
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